Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial
Zydus Pharmaceuticals recalls Verapamil Hydrochloride Injection due to cross contamination risk. Affected lots have specific NDC numbers and expiration dates. Patients should contact the manufacturer for details.
Lower-risk recall
Cross contamination with other products.
Contact the company & request your remedy
What happened, in plain English
Zydus Pharmaceuticals is recalling Verapamil Hydrochloride Injection, 5 mg / 2mL, because it may have been cross contaminated with other products. This could pose a risk to patients using the medication. Read more at govinfonow.com/recall/32594-zydus-verapamil-injection-recall-cross-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32594-zydus-verapamil-injection-recall-cross-contamination-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0592-2024
Cite this page
“Zydus Verapamil Injection Recall: Cross Contamination Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32594-zydus-verapamil-injection-recall-cross-contamination-risk. Based on FDA recall #D-0592-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0592-2024%22&limit=1).
Why it’s dangerous
Cross contamination with other products can occur during manufacturing. This may lead to unintended medication mix-ups, potentially causing adverse effects in patients.
Who’s affected
Patients prescribed Verapamil Hydrochloride Injection by a healthcare provider. Those using the specific lot numbers and expiration dates listed in the recall are most at risk.
How to tell if you have this one
Check for NDC numbers 70710-1643-1 (carton) and 70710-1643-5 (carton) on the packaging. The affected lots include L300255, L300262 (expiring 07/31/2025) and L300263 (expiring 08/31/2025).
- Brand
Zydus Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Ongoing- Distribution
Nationwide in the USA
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0592-2024 | Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,; Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025 | 170,755 vials | 70710-1643-5, 70710-1643-7, 70710-1644-1, 70710-1644-5, 70710-1643-1 |
| D-0593-2024 | Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534, Vial NDC: 70710-1644-1, Carton NDC: 70710-1644-5.; Lot L300269, Exp Date 07/31/2025 | 8020 vials | 70710-1643-5, 70710-1643-7, 70710-1644-1, 70710-1644-5 |
What to do — step by step
Check Product Details
Identify the NDC numbers and lot numbers on your Verapamil Hydrochloride Injection packaging to determine if it is affected.
Questions people ask
Is this product safe to use?
The recall indicates a potential cross contamination risk, but the product is safe to use if it is not in the affected lots listed.
What should I do if I have the affected product?
Contact Zydus Pharmaceuticals (USA) Inc directly for instructions on how to handle the affected product.
How can I check if my product is affected?
Check the NDC numbers on the packaging: 70710-1643-1 or 70710-1643-5, and lot numbers L300255, L300262 (expiring 07/31/2025) or L300263 (expiring 08/31/2025).
Contact Zydus Pharmaceuticals
We’ve drafted a message you can send Zydus Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0592-2024 — Zydus Pharmaceuticals Zydus Pharmaceuticals Hello, I own a Zydus Pharmaceuticals that is covered by recall D-0592-2024 from Zydus Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0592-2024 (July 2, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0592-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.